Group items tagged

The Global Magnetic Resonance Imaging (MRI) System Market Research Report 2018 gives an in-depth valuation of the Magnetic Resonance Imaging (MRI) System that includes technologies, key trends, market share, size, challenges, opportunities, future forecast, value chain, and strategies. The Research report gives a complete overview of the market and contains a Future trend, Current Growth Factors. The study is segmented by products type, application/end-users.

Biological Safety Cabinet Research reports cover detailed competitive outlook including the market share and company profiles of the key participants operating in the Global market. The Biological Safety Cabinet market report provides an in-depth overview of Product Specification, technology, product type and production Analysis considering major factors such as Revenue, Cost, Gross and Gross Margin

PRODUCT DESCRIPTION SLIQUE HAIR THREADING SYSTEM IN PAKISTAN Using the hottest trend in salon/spa hair removal, "Hair Threading", Slique is a new innovative device that can give women that perfect hair free skin model look easily from the comfort of their own home. Unlike tweezing one hair at a time, Slique efficiently removes an entire straight line of hairs, all at the same time…leaving the skin hair free and smooth.Slique Hair Threading System Opportunity Details Hairdressing salons to get rid of unwanted hair on your face no longer necessary to spend time and money! Threading Facial Hair Removal Slique within minutes at any time with the flaring tool and you can have a smooth skin. Promoskop Slique Threading Facial Hair Removal Device Facial hair removal is now much easier and more practical to Slique … Face down with a rope Slique hair removal kit is very easy to clean, well-groomed women slique preference, have a look in the mirror yourself with confidence. Whereas the second person to face with Slique or beauty specialist in your area do not need feathers. What is Slique facial hair removal? In fact, facial hair a rope-making that has been used since ancient times, and facial hair removal method of hair removal. Compressed in the loop of a rope made of hair removal of the ilmikte. With this method, the root hairs and can face. Looking forward to a quick and clean method of hair removal as well as the network does not irritate the skin. Promoskop From one generation to the old arts of Asia and the Middle East, looking forward to that period of time is always a preferred hair removal method for facial cleansing. What is the rope of hair removal? Rope of hair removal hair removal method that has been used since ancient times. Ilmikte loop of a rope made of hair that can be defined as compressed. Is the root hairs. There are many advantages of getting a feather rope. A way that serves its purpose fully. Quick and clean. Plus, it does not irritate the sk

The global predictive dialer software market size was valued at USD 1.03 billion in 2020 and is expected to expand at a CAGR of 37.0% from 2021 to 2028.

The global healthcare additive manufacturing market size is valued at USD 6.4 billion in 2028 and is anticipated to grow at a CAGR of 21.8%

The global clinical laboratory service market size is expected to reach USD 288.7 billion by 2028, according to a new report

The global capnography devices market size was valued at USD 510.7 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 9.7% from 2021 to 2028.

The global market for chronic kidney disease drugs is expected to witness single-digit growth during 2019-2025. The drug pipeline of chronic kidney disease looks promising with novel therapeutic approaches, such as cell therapy, likely to enhance the market growth opportunities. However, the competition from biosimilars and complex drug development processes are impeding the market growth. Over the period, extensive research is being done to fill the unmet needs' gap. The advances in the arena of regenerative treatment have come up with budding advancement of cell therapies that help regeneration and repairing of the kidneys. Cell therapy is proficient of refining the fundamental functioning capability of the kidney. Uncontrolled high blood pressure and diabetes are the leading causes of kidney failure globally.

Infoholic's market research report predicts that the global leukemia therapeutics market will grow at a CAGR of 6.2% during the forecast period 2019-2025. Leukemia refers to the group of blood cancer that usually develops in the bone marrow, resulting in the formation of abnormal blood cells. Leukemia is subdivided into lymphoblastic or lymphocytic leukemias and myeloid or myelogenous leukemias that include acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML). The report provides complete details about the sub-segment of the global leukemia therapeutics market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Boots on Thursday unveiled its Christmas campaign for 2021, 'Bags of Joy', with a festive film featuring BAFTA nominated actor Jenna Coleman. Coleman stars as modern heroine Joy in the uplifting film, directed by Academy Award winner Tom Hooper, with a magical bag that delivers the perfect gifts to her friends and family at every opportunity. Boots said the magical bag of joy represents the 1000s of gifts available at Boots, including beauty, fragrance, homeware, electrical beauty and stocking fillers, with something for everyone this year. "After the challenges of the past 18 months, we felt it was more important than ever for Boots to bring joy to the nation by telling an uplifting, positive story at Christmas," Pete Markey, Chief Marketing Officer at Boots UK, said.

Pharmacists and pharmacy technicians are set to receive up to £15.9 million over the next four years which will help them thrive in multidisciplinary healthcare teams and enable expansion of frontline staff in primary and community care. The funding, which is part of the Pharmacy Integration Programme allocation, will improve registered pharmacy professionals' skills, through a range of training and development opportunities. The programme is a part of education reform for pharmacy professionals and will allow them to identify career pathways. Health Education England and NHS England will work in partnership to develop "a formal portfolio recognition process to identify the existing skills, training and experience gained by pharmacists working in primary care, allowing them to work more flexibly and better support GP services", HEE said in a statement today (November 8).

US pharmaceutical giant Johnson & Johnson on Friday (November 12) announced plans to break up into two listed companies, separating its consumer health arm that sells Band-Aids and Tylenol from its pharmaceutical division. Johnson & Johnson said in a statement it will create "two global leaders that are better positioned to deliver improved health outcomes for patients and consumers through innovation." It plans to complete the separation in 18-24 months, creating two publicly traded companies. CEO Alex Gorsky said the decision was made following a "comprehensive review." The board and management believe the split is "the best way to accelerate our efforts to serve patients, consumers, and healthcare professionals, create opportunities for our talented global team, drive profitable growth, and -- most importantly -improve healthcare outcomes for people around the world," he said.

The Association of the British Pharmaceutical Industry (ABPI) has supported the Department of Health and Social Care's recommendation to 'aggressively expedite and roll out new medicines' that have gone through trials. The ABPI welcomes government report on cancer services in England and the opportunity it provides to refocus how the pharmaceutical industry, NHS and government can improve the lives of cancer patients. David Watson, executive director, Patient Access at the ABPI, said: "Despite progress, UK patients still have much worse five-year survival rates for many cancers than those in similar nations. Early diagnosis and fast and equal access to the latest treatments for all patients is key to reversing poor trends in NHS cancer care. "We are pleased that the report reflects concerns about variable access to cancer medicines. We support the Committee's recommendations to 'aggressively expedite and roll out new medicines' that have gone through trials and to ensure regulatory innovation results in swift uptake in the UK.

The General Pharmaceutical Council (GPhC) has launched a new draft 'Equality Guidance' for pharmacies to tackle discrimination and make sure that everyone can access safe and effective person-centred pharmacy care. GPhC's consultation is seeking views on "the structure and language of the guidance, if anything is missing and the impacts on patients and members of the public, pharmacy staff, pharmacy owners, and individuals or groups sharing any of the protected characteristics." The regulator said the draft guidance is designed to support pharmacy owners to: demonstrate that they are meeting our standards for registered pharmacies fulfil their legal and regulatory duties in relation to equality help protect the rights of individuals advance equal opportunities for staff, patients and the wider public help improve the experience and healthcare outcomes of patients and members of the public.

While thanking the provisionally registered pharmacists and their employers for supporting NHS services during the pandemic, the General Pharmaceutical Council (GPhC) has asked the 63 eligible candidates to join the main register by January 31 to continue practicing. A total number of 4,799 provisionally-registered pharmacists have been on the provisional register since it was introduced in July 2020 in response to the Covid-19 pandemic, which had affected the registration assessment schedule. As of Tuesday (January 18), 237 were still on the provisional register, of which 84 have begun the process to join the main register, 90 did not sat an assessment, while 63 eligible candidates are yet to start their application. The register enabled trainees who had completed their training to support NHS services and provide patient care effectively as provisionally-registered pharmacists, while they waited to sit the registration assessment. After providing three potential opportunities to trainees to sit the registration assessment - in March, July and November 2021, the provisional register will close on January 31, 2022.

The Centre for Pharmacy Postgraduate Education (CPPE) has announced launch of the new e-learning programme on controlled drugs in chronic pain to support patients. The programme launched on Monday (January 17), aims to support pharmacy professionals to develop the knowledge, skills and behaviours to support patients to use prescribed controlled drugs safely with a focus on chronic pain. The new programme will open new opportunities for pharmacy professionals to improve patient care, in relation to the safe prescribing and use of controlled drugs.

Choosing to participate in the medical field is a wonderful opportunity. But perhaps you'd rather branch off a little bit from the norm and pick a slightly different career. If that's what you're hoping to achieve, then becoming a pharmacist may just be the right choice for you. Here's what you need to know before becoming a pharmacist and how you can easily pay for your degree. WHAT DOES A PHARMACIST DO? Honestly, it's surprising to think how many people underestimate the pharmacy profession. Some genuinely think that they're just people who give you medicine over the counter. And while this is certainly one of their duties, a pharmacist is so much more than that. Believe it or not, pharmacists are trained medical professionals.

Community pharmacy contractors are likely to receive more referrals from NHS 111 for the Community Pharmacist Consultation Service (CPCS) following a review of the NHS Pathway algorithms, NHS England and NHS Improvement (NHSE&I) announced on Friday (January 14). The review, conducted by an expert group of Integrated Urgent Care clinicians and pharmacists, led to inclusion of more minor illness symptoms for referral to the CPCS from NHS 111. The reviews based on data from 2021, showed it could generate 275,000 additional referral opportunities annually. With the introduction of changes, three new condition types (scratches and grazes, teething, sinusitis) and general health information requests will be added.

Workforce issues, staff retention and capacity continues to be a big concern for the Local Pharmaceutical Committee as it discussed the topics at a recent meeting with the Pharmaceutical Services Negotiating Committee (PSNC). The meeting, attended by delegates from 66 LPCs, focused on the current challenges faced by community pharmacies as well as the planning for the next year. Around 64 per cent of delegates said workforce was the top challenge faced by pharmacy contractors, and suggested reducing the migration of pharmacists to Primary Care Networks (PCNs). Other suggestions included - "improving the development opportunities available for pharmacists and their teams, and rebranding the profession to make community pharmacy a more attractive route for young graduates." On the development of Integrated Care Systems (ICS), the majority of respondents were positive about their LPC's engagement in the new setting.